|
Jan 30
|
Jim Cramer Says Merck & Co. (MRK) Has Been a One-way Stock Even Though CEO Rob Davis Has Done Some Terrific Things
|
|
Jan 30
|
Merck Announces Decision to Stop Phase 3 HYPERION Trial Evaluating WINREVAIR™ (sotatercept-csrk) Early and Move to Final Analysis
|
|
Jan 29
|
Is Merck & Co., Inc. (MRK) Among the Best Blue Chip Stocks to Buy Under $100?
|
|
Jan 29
|
3 Prominent US Dividend Stocks Yielding Up To 4.2%
|
|
Jan 29
|
The RFK Jr. Effect: Biotech Stocks Brace For 'Games' In Senate Hearings
|
|
Jan 29
|
Merck & Co., Inc. (MRK): Is This Healthcare Stock A Good Buy?
|
|
Jan 28
|
Merck Announces Second-Quarter 2025 Dividend and $10 Billion Share Repurchase Authorization
|
|
Jan 28
|
Is Merck & Co. (MRK) Among Kevin O’Leary’s Stock Picks for 2025?
|
|
Jan 28
|
Merck (MRK) Earnings Expected to Grow: Should You Buy?
|
|
Jan 28
|
Merck Q4 Earnings Coming Up: Buy, Hold or Sell MRK Stock Now?
|
|
Jan 27
|
Is Merck & Co. (MRK) the Best Depressed Stock to Invest in Now?
|
|
Jan 27
|
FDA Grants Priority Review to Merck’s Application for WELIREG® (belzutifan) for the Treatment of Patients With Advanced Pheochromocytoma and Paraganglioma (PPGL)
|
|
Jan 25
|
Jim Cramer Says Merck & Co., Inc. (MRK) ‘Needs To Have China Be Less Of Our Enemy’
|
|
Jan 25
|
Is Merck & Co., Inc. (MRK) the Best Dow Stocks to Buy Right Now?
|
|
Jan 24
|
Why Is Billionaire Prem Watsa Bullish on Merck & Co., Inc. (MRK) Now?
|
|
Jan 24
|
Merck and Eisai Provide Update on Phase 3 LEAP-015 Trial Evaluating KEYTRUDA® (pembrolizumab) Plus LENVIMA® (lenvatinib) in Combination with Chemotherapy in Patients with Certain Types of Gastroesophageal Adenocarcinoma
|
|
Jan 24
|
The total return for Merck (NYSE:MRK) investors has risen faster than earnings growth over the last three years
|
|
Jan 20
|
Earnings Season Scorecard and Fresh Analyst Reports for Chevron, Merck & Others
|
|
Jan 20
|
Why WEC Energy, Fifth Third Bancorp And Merck Are Winners For Passive Income
|
|
Jan 20
|
Merck & Co., Inc. (MRK): A Bull Case Theory
|